References
Loh HH, Brase DA, Sampath-Khanna S, Mar JB, Way EL, Li CH (1976) Beta-endorphin in vitro inhibition of striatal dopamine release. Nature 264:567–568
Bloom F, Segal D, Ling N, Guillemin R (1976) Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science 194:630–632
Agnoli A, Ruggieri S, Falaschi P, Mearelli S, Del Roscio S, D'Urso R, Frajese G (1980) Are the enkephalins involved in Parkinson’s disease? Clinical and neuroendocrine response to naloxone administration. Adv Biochem Psychopharmacol 22:511–521
Trabucchi M, Bassi S, Frattola L (1982) Effect of naloxone on the “on-off” syndrome in patients receiving long-term levodopa therapy. Arch Neurol 39:120–121
Nutt JG, Rosin AJ, Eisler T, Calne DB, Chase TN (1978) Effect of an opiate antagonist on movement disorders. Arch Neurol 35:810–811
McEvoy GK (ed) Naloxone hydrochloride. In: AHFS Drug Information, Bethesda, pp 2236–2239
Fox S, Silverdale M, Kellett M, Davies R, Steiger M, Fletcher N, Crossman A, Brotchie J (2004) Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson’s disease. Mov Disord 19:554–560
Sgroi S, Tonini R (2018) Opioidergic modulation of striatal circuits, implications in Parkinson’s disease and levodopa induced dyskinesia. Front Neurol 9:524
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Consent to participate
Obtained from all Authors.
Consent for publication
Obtained from all Authors.
Ethical approval
N/A. Obtained informed consent.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Belfiore, G., Terranova, R., Mostile, G. et al. Acute motor effects induced by opioid antagonists in Parkinson’s disease: could naloxone be a rescue therapy?. Neurol Sci 42, 2553–2554 (2021). https://doi.org/10.1007/s10072-020-04955-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04955-9